Intravenous Topiramate: Safety and Pharmacokinetics Following a Single Dose in Patients with Epilepsy or Migraines Taking Oral Topiramate Publication Intravenous Topiramate: Safety and Pharmacokinetics Following a Single Dose in Patients with Epilepsy or Migraines Taking Oral Topiramate Although topiramate is widely prescribed for epilepsy and migraine, there is no intravenous product. We…Danielle Pillsbury2013 年 6 月 1 日
Intravenous Topiramate: Comparison of Pharmacokinetics and Safety with the Oral Formulation in Healthy Volunteers Publication Intravenous Topiramate: Comparison of Pharmacokinetics and Safety with the Oral Formulation in Healthy Volunteers Although oral topiramate (TPM) products are widely prescribed for migraines and epilepsy, injectable TPM is not available…Danielle Pillsbury2013 年 6 月 1 日
Application of In Vitro-In Vivo Extrapolation (IVIVE) and Physiologically-based Pharmacokinetic Modeling to Investigate the Impact of the CYP2C8 Polymorphism on Rosiglitazone Exposure Publication Application of In Vitro-In Vivo Extrapolation (IVIVE) and Physiologically-based Pharmacokinetic Modeling to Investigate the Impact of the CYP2C8 Polymorphism on Rosiglitazone Exposure The purpose of this study was to predict the impact of the CYP2C8*3 genotype on…Danielle Pillsbury2013 年 6 月 1 日
Evaluation of an In Silico PBPK Postbariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and Cyclosporine Publication Evaluation of an In Silico PBPK Postbariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and Cyclosporine An increasing prevalence of morbid obesity has led to dramatic increases in the number of…Danielle Pillsbury2013 年 6 月 1 日
Characterizing Systemic Exposure of Inhaled Drugs: Application to the Long-acting β2-agonist PF-00610355 Publication Characterizing Systemic Exposure of Inhaled Drugs: Application to the Long-acting β2-agonist PF-00610355 PF-00610355 is an orally inhaled long-acting β2-adrenoreceptor agonist that is being developed for the once-daily…Danielle Pillsbury2013 年 6 月 1 日
Age Related Changes in Fractional Elimination Pathways for Drugs: Assessing the Impact of Variable Ontogeny on Metabolic Drug-drug Interactions Publication Age Related Changes in Fractional Elimination Pathways for Drugs: Assessing the Impact of Variable Ontogeny on Metabolic Drug-drug Interactions The magnitude of any metabolic drug-drug interactions (DDIs) depends on fractional importance of inhibited pathway…Danielle Pillsbury2013 年 5 月 30 日
The Future of the Pharmaceutical Sciences and Graduate Education: Recommendations from the AACP Graduate Education Special Interest Group Publication The Future of the Pharmaceutical Sciences and Graduate Education: Recommendations from the AACP Graduate Education Special Interest Group Despite pharma's recent sea change in approach to drug discovery and development, U.S. pharmaceutical sciences…Danielle Pillsbury2013 年 5 月 13 日
Investigation of the Role of Fc-γ-R and FcRn in mAb Distribution to the Brain Publication Investigation of the Role of Fc-γ-R and FcRn in mAb Distribution to the Brain To evaluate the role of Fc receptors (FcR) on IgG distribution to the brain, the disposition of 8C2, a murine…Danielle Pillsbury2013 年 5 月 6 日
Biodistribution and Pharmacokinetics of EGFR-targeted Thiolated Gelatin Nanoparticles Following Systemic Administration in Pancreatic Tumor-bearing Mice Publication Biodistribution and Pharmacokinetics of EGFR-targeted Thiolated Gelatin Nanoparticles Following Systemic Administration in Pancreatic Tumor-bearing Mice The objective of this study was to evaluate qualitative and quantitative biodistribution of epidermal growth…Danielle Pillsbury2013 年 5 月 6 日
Synergistic Interactions between Sorafenib and Everolimus in Pancreatic Cancer Xenografts in Mice Publication Synergistic Interactions between Sorafenib and Everolimus in Pancreatic Cancer Xenografts in Mice Molecular targeting of cellular signaling pathways is a promising approach in cancer therapy, but often…Danielle Pillsbury2013 年 5 月 1 日